Highlights Of Prescribing Information

These highlights do not include all the information needed to use ZANAFLEX® safely and effectively.

See full prescribing information for ZANAFLEX.

  • ZANAFLEX® (tizanidine hydrochloride) capsules, for oral use
  • ZANAFLEX® (tizanidine hydrochloride) tablets, for oral use

Warnings and Precautions

  • Hypotension: monitor for signs and symptoms of hypotension, in particular in patients receiving concurrent antihypertensives; Zanaflex should not be used with other α2-adrenergic agonists
  • Risk of liver injury: monitor ALTs; discontinue Zanaflex if liver injury occurs
  • Sedation: Zanaflex may interfere with everyday activities; sedative effects of Zanaflex, alcohol, and other CNS depressants are additive
  • Hallucinations: consider discontinuation of Zanaflex
  • Less potent inhibitors of CYP1A2: may cause hypotension, bradycardia, or excessive drowsiness, use caution if Zanaflex is used with less potent inhibitors of CYP1A2, e.g., zileuton, other fluoroquinolones, antiarrhythmics, cimetidine, famotidine, oral contraceptives, acyclovir, and ticlopidine
  • Renal impairment (creatinine clearance < 25 mL/min): use Zanaflex with caution, and monitor closely for dry mouth, somnolence, asthenia and dizziness as indicators of potential overdose

  • Adverse Reactions

  • The most common adverse reactions (greater than 2% of 264 patients taking tizanidine and greater than in placebo-treated patients in three multiple dose, placebo-controlled studies) were dry mouth, somnolence, asthenia, dizziness, urinary tract infection, constipation, liver function tests abnormal, vomiting, speech disorder, amblyopia, urinary frequency, flu syndrome, SGPT/ALT increased, dyskinesia, nervousness, pharyngitis, and rhinitis

    To report SUSPECTED ADVERSE REACTIONS, contact Legacy Pharma at 1-800-727-7151 or FDA at
    1-800-FDA-1088 or www.fda.gov/medwatch.

  • Use In Specific Populations

  • Pregnancy: Based on animal data, may cause fetal harm
  • Geriatric use: Zanaflex should be used with caution in elderly patients because clearance is decreased four-fold (8.5)

Please see Full Prescribing Information, including Boxed Warning, for ZANAFLEX CAPSULES/ZANAFLEX TABLETS.

Let's get in touch

Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours.
1-800-727-7151